Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

OXGN:US

1.4400 USD 0.0100 0.70%

As of 20:10:00 ET on 05/29/2015.

Company Profile for OXiGENE Inc (OXGN)

OXiGENE Inc. is a pharmaceutical company that develops therapeutics to treat cancer and eye diseases. The Company focuses on the clinical advancement of drug candidates that selectively disrupt abnormal blood vessels associated with solid tumor progression and visual impairment.

Contact Information

OXiGENE Inc

701 Gateway Boulevard
Suite 210
South San Francisco, CA 94080
United States
Phone: 1-650-635-7000
Fax: 1-650-635-7001

Key Executives for OXiGENE Inc (OXGN)

William D Schwieterman "Bill"President/CEODavid J Chaplin "Dai"Chief Scientific Officer
Barbara RichingVP/CFO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil